Yüksel Ürün: New study shows CA-125 as a potential biomarker for RMC
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on X about recent paper by Sandra L. Grimm et al., titled “CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation” published on AACR Journals.
Authors: Sandra L. Grimm, Menuka Karki, Kyle A. Blum, Jean-Philippe Bertocchio, Rong He, Durga N. Tripathi, Niki M. Zacharias, Justin M. Lebenthal, Rahul A. Sheth, Priya Rao, Giannicola Genovese, Zhen Lu, Robert C. Bast, Davis R. Ingram, Rossana Lazcano, Khalida M. Wani, Wei-Lien Wang, Alexander J. Lazar, Nizar M. Tannir, Cheryl L. Walker, Cristian Coarfa, Pavlos Msaouel
“Renal Medullary Carcinoma (RMC) and CA-125
New study shows CA-125 as a potential biomarker for RMC! Elevated serum CA-125 correlates with metastatic burden, opening doors for better monitoring and targeted therapy.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023